| Interleukin‐23: as a drug target for autoimmune inflammatory diseases C Tang, S Chen, H Qian, W Huang Immunology 135 (2), 112-124, 2012 | 397 | 2012 |
| pH-sensitive peptide hydrogel for glucose-responsive insulin delivery X Li, M Fu, J Wu, C Zhang, X Deng, A Dhinakar, W Huang, H Qian, L Ge Acta biomaterialia 51, 294-303, 2017 | 145 | 2017 |
| Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development Z Li, Q Qiu, X Geng, J Yang, W Huang, H Qian Expert opinion on investigational drugs 25 (8), 871-890, 2016 | 87 | 2016 |
| Design and synthesis of thiourea derivatives containing a benzo [5, 6] cyclohepta [1, 2-b] pyridine moiety as potential antitumor and anti-inflammatory agents W Liu, J Zhou, T Zhang, H Zhu, H Qian, H Zhang, W Huang, R Gust Bioorganic & medicinal chemistry letters 22 (8), 2701-2704, 2012 | 82 | 2012 |
| Free fatty acid receptor 1 (FFAR1) as an emerging therapeutic target for type 2 diabetes mellitus: recent progress and prevailing challenges Z Li, X Xu, W Huang, H Qian Medicinal research reviews 38 (2), 381-425, 2018 | 79 | 2018 |
| Performance of doxorubicin-conjugated gold nanoparticles: regulation of drug location T Cui, JJ Liang, H Chen, DD Geng, L Jiao, JY Yang, H Qian, C Zhang, ... ACS applied materials & interfaces 9 (10), 8569-8580, 2017 | 76 | 2017 |
| Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates J Han, L Sun, Y Chu, Z Li, D Huang, X Zhu, H Qian, W Huang Journal of medicinal chemistry 56 (24), 9955-9968, 2013 | 75 | 2013 |
| Structure–activity relationships of a snake cathelicidin-related peptide, BF-15 W Chen, B Yang, H Zhou, L Sun, J Dou, H Qian, W Huang, Y Mei, J Han Peptides 32 (12), 2497-2503, 2011 | 63 | 2011 |
| TNF-α inhibitors with anti-oxidative stress activity from natural products J Li, H Zhang, W Huang, H Qian, Y Li Current topics in medicinal chemistry 12 (13), 1408-1421, 2012 | 58 | 2012 |
| Design, synthesis and structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes Z Li, Q Qiu, X Xu, X Wang, L Jiao, X Su, M Pan, W Huang, H Qian European Journal of Medicinal Chemistry 113, 246-257, 2016 | 56 | 2016 |
| Histology and antitumor activity study of PTX-loaded micelle, a fluorescent drug delivery system prepared by PEG-TPP H Li, J Li, X He, B Zhang, C Liu, Q Li, Y Zhu, W Huang, W Zhang, H Qian, ... Chinese Chemical Letters 30 (5), 1083-1088, 2019 | 55 | 2019 |
| Novel coumarin modified GLP‐1 derivatives with enhanced plasma stability and prolonged in vivo glucose‐lowering ability J Han, L Sun, X Huang, Z Li, C Zhang, H Qian, W Huang British journal of pharmacology 171 (23), 5252-5264, 2014 | 49 | 2014 |
| Novel fatty chain-modified glucagon-like peptide-1 conjugates with enhanced stability and prolonged in vivo activity J Han, X Huang, L Sun, Z Li, H Qian, W Huang Biochemical Pharmacology 86 (2), 297-308, 2013 | 44 | 2013 |
| Injectable self-assembled peptide hydrogels for glucose-mediated insulin delivery M Fu, C Zhang, Y Dai, X Li, M Pan, W Huang, H Qian, L Ge Biomaterials science 6 (6), 1480-1491, 2018 | 43 | 2018 |
| Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives … Q Qiu, B Liu, J Cui, Z Li, X Deng, H Qiang, J Li, C Liao, B Zhang, W Shi, ... Journal of Medicinal Chemistry 60 (8), 3289-3302, 2017 | 42 | 2017 |
| Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives W Liu, J Zhou, K Bensdorf, H Zhang, H Liu, Y Wang, H Qian, Y Zhang, ... European journal of medicinal chemistry 46 (3), 907-913, 2011 | 42 | 2011 |
| A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects J Zhou, X Cai, X Huang, Y Dai, L Sun, B Zhang, B Yang, H Lin, W Huang, ... European journal of medicinal chemistry 138, 1158-1169, 2017 | 40 | 2017 |
| Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane Y Dai, X Cai, W Shi, X Bi, X Su, M Pan, H Li, H Lin, W Huang, H Qian Amino acids 49, 1601-1610, 2017 | 40 | 2017 |
| Exploration of 2-((pyridin-4-ylmethyl) amino) nicotinamide derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance Q Qiu, W Shi, Z Li, B Zhang, M Pan, J Cui, Y Dai, W Huang, H Qian Journal of Medicinal Chemistry 60 (7), 2930-2943, 2017 | 39 | 2017 |
| A new isochroman-4-one derivative from the peel of Musa sapientum L. and its total synthesis H Qian, WL Huang, XM Wu, HB Zhang, JP Zhou, WC Ye Chinese Chemical Letters 18 (10), 1227-1230, 2007 | 39 | 2007 |
